Balyasny Asset Management
CRVS icon

Balyasny Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Balyasny Asset Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,827
Closed -$184K – 2083
2025
Q1 		$184K Buy
57,827
+9,492
+20% +$30.2K ﹤0.01% 1832
2024
Q4 		$259K Buy
+48,335
New +$259K ﹤0.01% 1680